Chart - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Export Countries
2020
2021
2022
2023
2024
Belgium
54.168.661
154.427.088
497.362.301
66.725.146
50.413.914
United States
460.797
115.231.633
184.684.034
4.793.914
4.188.124
France
50.448.567
40.183.790
53.542.932
39.020.631
50.361.017
Netherlands
4.786
21.914.488
134.052
26.389.141
37.802.735
South Korea
9.192.000
21.555.000
6.452.000
4.025.000
10.629.000
Russia
26.229.091
20.335.050
Japan
22.585.842
4.641.839
5.039.863
1.565.626
1.573.518
Brazil
6.000
1.330.706
5.756.779
4.504.073
5.801.698
China
4.180.363
4.968.392
859.260
1.396.406
1.270.510
Italy
1.168.405
1.245.617
931.395
1.155.296
6.079.531
Others
5.899.898
6.429.896
4.630.691
5.444.495
4.999.572
Total
174,344,410
392,263,499
759,393,307
155,019,729
173,119,618
Chart - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Date
Export Countries
03 - 2025
04 - 2025
05 - 2025
06 - 2025
07 - 2025
Belgium
3.462.560
5.274.090
3.597.768
4.383.866
3.683.622
Netherlands
6.617.846
3.500.317
1.470.246
18.734
14.282
South Korea
106.000
306.000
29.000
2.087.000
1.763.000
France
634.164
1.719.885
1.370.373
293.069
United States
3.051.971
576.369
95.479
China
561.635
101.907
280.897
150.783
53.526
Denmark
158.764
678.581
189.049
62.851
43.482
Israel
287.000
78.000
208.000
144.000
202.000
Japan
281.978
253.890
Czech Republic
24.148
12.641
50.366
17.162
Others
73.046
27.399
29.499
70.520
130.116
Total
14,977,134
12,557,169
5,804,458
8,687,863
6,200,259
Chart - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Import Countries
2020
2021
2022
2023
2024
United States
39.050
16.116
37.679
65.409
Germany
4.262
3.659
4.872
52.813
5.358
Ireland
435
7.047
12.881
5.908
13.743
Belgium
10
9.634
21.950
Italy
22.665
2.458
Sweden
1.978
10.525
3.563
34
Spain
754
1.312
4.428
4.613
4.257
South Korea
15.000
France
474
956
23
3.334
173
Netherlands
14
37
813
713
167
Others
490
181
167
1.669
199
Total
45,480
53,952
33,720
134,925
113,746
Chart - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Date
Import Countries
03 - 2025
04 - 2025
05 - 2025
06 - 2025
07 - 2025
United States
4.505
5.771
22.070
Belgium
2.490
1.655
1.703
1.540
1.522
Ireland
715
966
581
698
840
Spain
173
839
625
490
Germany
140
198
130
03
1.041
France
127
31
55
Hungary
02
02
02
02
01
Cyprus
01
01
Denmark
01
Total
8,153
9,431
2,447
24,994
3,894
Chart - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Export Countries
2020
2021
2022
2023
2024
Importaciones
Belgium
54.168.661
154.427.088
497.362.301
66.725.146
50.413.914
United States
460.797
115.231.633
184.684.034
4.793.914
4.188.124
France
50.448.567
40.183.790
53.542.932
39.020.631
50.361.017
Netherlands
4.786
21.914.488
134.052
26.389.141
37.802.735
South Korea
9.192.000
21.555.000
6.452.000
4.025.000
10.629.000
Russia
26.229.091
20.335.050
Japan
22.585.842
4.641.839
5.039.863
1.565.626
1.573.518
Brazil
6.000
1.330.706
5.756.779
4.504.073
5.801.698
China
4.180.363
4.968.392
859.260
1.396.406
1.270.510
Italy
1.168.405
1.245.617
931.395
1.155.296
6.079.531
Others
5.899.898
6.429.896
4.630.691
5.444.495
4.999.572
Total
174,344,410
392,263,499
759,393,307
155,019,729
173,119,618
Date
Import Countries
2020
2021
2022
2023
2024
Exportaciones
United States
39.050
16.116
37.679
65.409
Germany
4.262
3.659
4.872
52.813
5.358
Ireland
435
7.047
12.881
5.908
13.743
Belgium
10
9.634
21.950
Italy
22.665
2.458
Sweden
1.978
10.525
3.563
34
Spain
754
1.312
4.428
4.613
4.257
South Korea
15.000
France
474
956
23
3.334
173
Netherlands
14
37
813
713
167
Others
490
181
167
1.669
199
Total
45,480
53,952
33,720
134,925
113,746
Chart - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD